HCM II Acquisition Corp. is a special purpose acquisition company (SPAC) focused on pursuing transformational mergers within the dynamic healthcare sector. Leveraging the deep industry expertise and extensive networks of its experienced management team, HCM II seeks to identify and capitalize on high-potential growth opportunities that align with emerging trends in healthcare technology and solutions. With a strategic commitment to driving shareholder value through effective acquisitions, HCM II is positioned to generate significant long-term returns for investors while contributing to advancements in the healthcare landscape.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | 0.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.48 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | $21.05M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on HONDW and any ticker you trade — then tracks every position and per-strategy win rate.